Risk factors associated with acute kidney injury in a cohort of hospitalized patients with COVID-19. 2023

Kateir Contreras-Villamizar, and Oscar Barbosa, and Ana Cecilia Muñoz, and Juan Sebastián Suárez, and Camilo A González, and Diana Carolina Vargas, and Martha Patricia Rodríguez-Sánchez, and Paola García-Padilla, and Martha Carolina Valderrama-Rios, and Jorge Alberto Cortés
Nephrology Unit, Kr 7 40 62 Hospital Universitario San Ignacio, 110231, Bogotá, DC, Colombia. kcontreras@husi.org.co.

Patients with COVID-19 have a high incidence of acute kidney injury (AKI), which is associated with mortality. The objective of the study was to determine the factors associated with AKI in patients with COVID-19. A retrospective cohort was established in two university hospitals in Bogotá, Colombia. Adults hospitalized for more than 48 h from March 6, 2020, to March 31, 2021, with confirmed COVID-19 were included. The main outcome was to determine the factors associated with AKI in patients with COVID-19 and the secondary outcome was estimate the incidence of AKI during the 28 days following hospital admission. A total of 1584 patients were included: 60.4% were men, 738 (46.5%) developed AKI, 23.6% were classified as KDIGO 3, and 11.1% had renal replacement therapy. The risk factors for developing AKI during hospitalization were male sex (OR 2.28, 95% CI 1.73-2.99), age (OR 1.02, 95% CI 1.01-1.03), history of chronic kidney disease (CKD) (OR 3.61, 95% CI 2.03-6.42), High Blood Pressure (HBP) (OR 6.51, 95% CI 2.10-20.2), higher qSOFA score to the admission (OR 1.4, 95% CI 1.14-1.71), the use of vancomycin (OR 1.57, 95% CI 1.05-2.37), piperacillin/tazobactam (OR 1.67, 95% CI 1.2-2.31), and vasopressor support (CI 2.39, 95% CI 1.53-3.74). The gross hospital mortality for AKI was 45.5% versus 11.7% without AKI. This cohort showed that male sex, age, history of HBP and CKD, presentation with elevated qSOFA, in-hospital use of nephrotoxic drugs and the requirement for vasopressor support were the main risk factors for developing AKI in patients hospitalized for COVID-19.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008297 Male Males
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000086382 COVID-19 A viral disorder generally characterized by high FEVER; COUGH; DYSPNEA; CHILLS; PERSISTENT TREMOR; MUSCLE PAIN; HEADACHE; SORE THROAT; a new loss of taste and/or smell (see AGEUSIA and ANOSMIA) and other symptoms of a VIRAL PNEUMONIA. In severe cases, a myriad of coagulopathy associated symptoms often correlating with COVID-19 severity is seen (e.g., BLOOD COAGULATION; THROMBOSIS; ACUTE RESPIRATORY DISTRESS SYNDROME; SEIZURES; HEART ATTACK; STROKE; multiple CEREBRAL INFARCTIONS; KIDNEY FAILURE; catastrophic ANTIPHOSPHOLIPID ANTIBODY SYNDROME and/or DISSEMINATED INTRAVASCULAR COAGULATION). In younger patients, rare inflammatory syndromes are sometimes associated with COVID-19 (e.g., atypical KAWASAKI SYNDROME; TOXIC SHOCK SYNDROME; pediatric multisystem inflammatory disease; and CYTOKINE STORM SYNDROME). A coronavirus, SARS-CoV-2, in the genus BETACORONAVIRUS is the causative agent. 2019 Novel Coronavirus Disease,2019 Novel Coronavirus Infection,2019-nCoV Disease,2019-nCoV Infection,COVID-19 Pandemic,COVID-19 Pandemics,COVID-19 Virus Disease,COVID-19 Virus Infection,Coronavirus Disease 2019,Coronavirus Disease-19,SARS Coronavirus 2 Infection,SARS-CoV-2 Infection,Severe Acute Respiratory Syndrome Coronavirus 2 Infection,COVID19,2019 nCoV Disease,2019 nCoV Infection,2019-nCoV Diseases,2019-nCoV Infections,COVID 19,COVID 19 Pandemic,COVID 19 Virus Disease,COVID 19 Virus Infection,COVID-19 Virus Diseases,COVID-19 Virus Infections,Coronavirus Disease 19,Disease 2019, Coronavirus,Disease, 2019-nCoV,Disease, COVID-19 Virus,Infection, 2019-nCoV,Infection, COVID-19 Virus,Infection, SARS-CoV-2,Pandemic, COVID-19,SARS CoV 2 Infection,SARS-CoV-2 Infections,Virus Disease, COVID-19,Virus Infection, COVID-19
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective
D012307 Risk Factors An aspect of personal behavior or lifestyle, environmental exposure, inborn or inherited characteristic, which, based on epidemiological evidence, is known to be associated with a health-related condition considered important to prevent. Health Correlates,Risk Factor Scores,Risk Scores,Social Risk Factors,Population at Risk,Populations at Risk,Correlates, Health,Factor, Risk,Factor, Social Risk,Factors, Social Risk,Risk Factor,Risk Factor Score,Risk Factor, Social,Risk Factors, Social,Risk Score,Score, Risk,Score, Risk Factor,Social Risk Factor
D017052 Hospital Mortality A vital statistic measuring or recording the rate of death from any cause in hospitalized populations. In-Hospital Mortality,Mortality, Hospital,Hospital Mortalities,In Hospital Mortalities,In Hospital Mortality,Inhospital Mortalities,Inhospital Mortality,Mortalities, In-house,Mortalities, Inhospital,Mortality, In-Hospital,Mortality, Inhospital,Hospital Mortalities, In,Hospital Mortality, In,In-Hospital Mortalities,In-house Mortalities,In-house Mortality,Mortalities, Hospital,Mortalities, In Hospital,Mortalities, In house,Mortalities, In-Hospital,Mortality, In Hospital,Mortality, In-house

Related Publications

Kateir Contreras-Villamizar, and Oscar Barbosa, and Ana Cecilia Muñoz, and Juan Sebastián Suárez, and Camilo A González, and Diana Carolina Vargas, and Martha Patricia Rodríguez-Sánchez, and Paola García-Padilla, and Martha Carolina Valderrama-Rios, and Jorge Alberto Cortés
January 2024, Jornal brasileiro de nefrologia,
Kateir Contreras-Villamizar, and Oscar Barbosa, and Ana Cecilia Muñoz, and Juan Sebastián Suárez, and Camilo A González, and Diana Carolina Vargas, and Martha Patricia Rodríguez-Sánchez, and Paola García-Padilla, and Martha Carolina Valderrama-Rios, and Jorge Alberto Cortés
January 2021, Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia,
Kateir Contreras-Villamizar, and Oscar Barbosa, and Ana Cecilia Muñoz, and Juan Sebastián Suárez, and Camilo A González, and Diana Carolina Vargas, and Martha Patricia Rodríguez-Sánchez, and Paola García-Padilla, and Martha Carolina Valderrama-Rios, and Jorge Alberto Cortés
January 2023, Critical care science,
Kateir Contreras-Villamizar, and Oscar Barbosa, and Ana Cecilia Muñoz, and Juan Sebastián Suárez, and Camilo A González, and Diana Carolina Vargas, and Martha Patricia Rodríguez-Sánchez, and Paola García-Padilla, and Martha Carolina Valderrama-Rios, and Jorge Alberto Cortés
May 2021, Nefrologia,
Kateir Contreras-Villamizar, and Oscar Barbosa, and Ana Cecilia Muñoz, and Juan Sebastián Suárez, and Camilo A González, and Diana Carolina Vargas, and Martha Patricia Rodríguez-Sánchez, and Paola García-Padilla, and Martha Carolina Valderrama-Rios, and Jorge Alberto Cortés
January 2021, Nefrologia,
Kateir Contreras-Villamizar, and Oscar Barbosa, and Ana Cecilia Muñoz, and Juan Sebastián Suárez, and Camilo A González, and Diana Carolina Vargas, and Martha Patricia Rodríguez-Sánchez, and Paola García-Padilla, and Martha Carolina Valderrama-Rios, and Jorge Alberto Cortés
April 2023, Biomedicines,
Kateir Contreras-Villamizar, and Oscar Barbosa, and Ana Cecilia Muñoz, and Juan Sebastián Suárez, and Camilo A González, and Diana Carolina Vargas, and Martha Patricia Rodríguez-Sánchez, and Paola García-Padilla, and Martha Carolina Valderrama-Rios, and Jorge Alberto Cortés
January 2021, Medicines (Basel, Switzerland),
Kateir Contreras-Villamizar, and Oscar Barbosa, and Ana Cecilia Muñoz, and Juan Sebastián Suárez, and Camilo A González, and Diana Carolina Vargas, and Martha Patricia Rodríguez-Sánchez, and Paola García-Padilla, and Martha Carolina Valderrama-Rios, and Jorge Alberto Cortés
June 2022, Kidney medicine,
Kateir Contreras-Villamizar, and Oscar Barbosa, and Ana Cecilia Muñoz, and Juan Sebastián Suárez, and Camilo A González, and Diana Carolina Vargas, and Martha Patricia Rodríguez-Sánchez, and Paola García-Padilla, and Martha Carolina Valderrama-Rios, and Jorge Alberto Cortés
May 2020, medRxiv : the preprint server for health sciences,
Kateir Contreras-Villamizar, and Oscar Barbosa, and Ana Cecilia Muñoz, and Juan Sebastián Suárez, and Camilo A González, and Diana Carolina Vargas, and Martha Patricia Rodríguez-Sánchez, and Paola García-Padilla, and Martha Carolina Valderrama-Rios, and Jorge Alberto Cortés
July 2020, Kidney international,
Copied contents to your clipboard!